|
|
| Line 63: |
Line 63: |
| | | | |
| | <div class="column full_size" > | | <div class="column full_size" > |
| − | <br> <br> <br> <br> <br>
| |
| − | <center><h1> Our Advisors </h1></center>
| |
| − | <br>
| |
| − | <br>
| |
| − | <font size="4">
| |
| − |
| |
| − | <table style="width:98%">
| |
| − |
| |
| − | <tr>
| |
| − | <td align="center"; width="50%"><img src="https://static.igem.org/mediawiki/2018/9/9a/T--Duke--Mike.jpeg" style="width:242px;height:300px;"></td>
| |
| − | <td align="center"; width="50%"><h4>Michael Lynch</h4>
| |
| − | <p><br>Michael Lynch MD, PhD is an assistant professor of both Chemistry and Biomedical Engineering at Duke University. He received both his Ph.D and M.D. at the University of Colorado at Boulder. His research focuses on modifying bacterial pathways to produce chemicals essential for applications such as pharmacology and industry.</p>
| |
| − | </td>
| |
| − | </tr>
| |
| − |
| |
| − | <tr bgcolor= "#efefef">
| |
| − | <td align="center"><h4>Adim Moreb</h4>
| |
| − | <p><br>Adim is a Ph.D. student in the Biomedical Engineering department. He joined the Lynch lab in 2015. His work focuses on improving the speed and efficiency of genome engineering in bacteria.</p>
| |
| − | </td>
| |
| − | <td align="center"><img src="https://static.igem.org/mediawiki/2018/8/8d/T--Duke--Adim.jpg" style="width:242px;height:300px;"></td>
| |
| − |
| |
| − | </tr>
| |
| − |
| |
| − | <tr>
| |
| − | <td align="center"><img src="https://static.igem.org/mediawiki/2018/b/b5/T--Duke--John.jpeg" style="width:242px;height:300px;"></td>
| |
| − | <td align="center"><h4>John Decker</h4>
| |
| − | <p><br>John is a Ph.D. student in the Department of Biomedical Engineering. Originally from middle Tennessee, he completed his undergraduate studies at the University of Alabama at Birmingham, where he earned a B.S. in Neuroscience and conducted research on eye movements and stereoscopic vision in humans. Outside of school and the lab, John enjoys the outdoors, literature, and fencing, and also holds a private pilot's license.</p>
| |
| − | </td>
| |
| − | </tr>
| |
| − |
| |
| − | <tr bgcolor= "#efefef">
| |
| − | <td align="center"><h4>Romel Menacho-</h4> <br> <h4> Melgar </h4>
| |
| − | <p><br>Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals</p>
| |
| − | </td>
| |
| − | <td align="center"><img src="https://static.igem.org/mediawiki/2018/e/ef/T--Duke--Romel.png" style="width:242px;height:300px;"></td>
| |
| − | </tr>
| |
| − |
| |
| − |
| |
| − | </table>
| |
| − | </font>
| |
| − | </div>
| |
| | | | |
| | | | |
